CBS 2019
CBSMD教育中心
中 文

Transcatheter Aortic Valve Replacement

Abstract

Recommended Article

A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve Replacement Minimalist transcatheter aortic valve replacement: The new standard for surgeons and cardiologists using transfemoral access? Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement Impact of myocardial fibrosis on left ventricular remodelling, recovery, and outcome after transcatheter aortic valve implantation in different haemodynamic subtypes of severe aortic stenosis Prognostic implications of baseline 6‐min walk test performance in intermediate risk patients undergoing transcatheter aortic valve replacement Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year Outcome Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement

Original ResearchVolume 73, Issue 9, March 2019

JOURNAL:J Am Coll Cardiol. Article Link

von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the Week

EV Belle, F Vincent, A Rauch et al. Keywords: aortic stenosis; biomarker; bioprosthesis; heart valve disease; mitral regurgitation; paravalvular regurgitation; point-of-care test; TAVR

FULL TEXT PDF